Atlas Trials

Study of the Role of PCSK9 and FXR in the Physiopathology of the Joint Dyslipidemia Associated to the Human Immunoresistance

Clinical trial NCT00422006 · COMPLETED

Trial details

NCT number
NCT00422006
Sponsor
Nantes University Hospital
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Obesity
Start date
2008-02-01
Primary completion
2013-11-01
Enrollment
111

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.